Drug Profile
Aciclovir oral - Emisphere
Alternative Names: Acyclovir oral - Emisphere; Oral acyclovir - EmisphereLatest Information Update: 14 Dec 2020
Price :
$50
*
At a glance
- Originator Emisphere Technologies
- Class Antivirals; Eye disorder therapies; Hypoxanthines; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 08 Dec 2020 Emisphere Technologies has been acquired by Novo Nordisk
- 23 Nov 2006 Phase-I clinical trials in Herpes simplex virus infections treatment in USA (PO)